An open-label, randomised, multicentre, phase III study of irinotecan liposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine in subjects who have not previously received chemotherapy for metastatic adenocarcinoma of the pancreas

Project: Research

Project Details

StatusActive
Effective start/end date18/03/2017/03/25

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • treatment safety
  • pancreatic cancer